Vir Biotechnology Inc (VIR)

47.68 -0.78  -1.61% NASDAQ Apr 21, 12:29 USD
View Full Chart
Price Chart
View All VIR News


View All Events


Date Type Description
05/12/2020 00:00 EDT Earnings Results Q1 2020 Earnings Results
05/20/2020 10:00 Agm 2019 Annual General Meeting
08/11/2020 00:00 Earnings Results Q2 2020 Earnings Results
11/10/2020 00:00 Earnings Results Q3 2020 Earnings Results
02/25/2021 00:00 Earnings Results Q4 2020 Earnings Results
05/12/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Vir Biotechnology Inc is a clinical-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB.
  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 12, 2021
  • Last Earnings Release: Feb. 25, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
SBIO ALPS Medical Breakthroughs ETF 4.18%
GERM ETFMG Treatments Testing and Adv ETF 3.06%
MOON Direxion Moonshot Innovators ETF 2.83%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 1.68%
BBC Virtus LifeSci Biotech Clinical Trls ETF 1.01%
BTEC Principal Healthcare Innovators ETF 0.89%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.